- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT06014281
Examinar los efectos de la práctica regular de meditación breve basada en Internet sobre la salud mental y el bienestar
Un ensayo de control aleatorio administrado por Internet para examinar los efectos de la práctica de meditación breve y regular sobre la salud mental y el bienestar
The study will examine the effects of online meditation training on stress and anxiety in healthy participants. It will also examine the dose-response relationship between the amount of daily focused attention meditation practice and established mental health outcome measures.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
This is a 16-week study with an 8-week meditation intervention, with a requirement of a minimum of 10 minutes of meditation practice each day. This study will recruit ~200 healthy subjects (18+ years) with no current or previous diagnosis of psychiatric or neurological disorders who are interested in learning about meditation but don't have long-term experience with meditation. Half of the participant pool will be randomly assigned to the meditation intervention, and the other half will get the wait-list control assignment. The control group will later receive its intervention, likely a few weeks after the completion of the active group's intervention. A focused-attention meditation technique (SOS meditation) will be used to train participants.
Changes in participants' physiological markers (e.g., HRV, physical activity, respiration rate, sleep quality) will be evaluated using passive activity monitoring devices (e.g., Fitbit). Intervention-related changes in mental health will be assessed using web-based mental health and well-being surveys. Improvements in cognitive functioning will be assessed using web-based psychological tasks.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
California
-
Stanford, California, Estados Unidos, 94305
- Dept. of Psychiatry, Stanford University
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Age ≥ 18 years
- Able to follow basic instructions for prescreening and scheduling
- Compliant with investigator instructions during the consent process and participation in the study
- Is not already a regular meditation practitioner
Exclusion Criteria:
- Age <18
- People with a current diagnosis of psychiatric or neurological disorders
- Be in current psychiatric treatment or medications
- Hospitalized for psychiatric disorders in the past year or so.
- Regular and long-term meditation practitioners
- Non-English speaking
- Non-USA mailing address to receive the activity tracker device
- Vision or hearing impairment severe enough to interfere with study participation
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Meditation group
Baseline to week 8: Subjects will be trained to meditate for 10 minutes daily, and several measures (questionnaires, cognitive tests, and physiological measurements) will be obtained to assess the efficacy of daily meditation practice on mental health and well being. Focused-attention meditation technique will be used to train participants. Specifically the SOS meditation technique will be employed. Week 8 to week 16: Subjects will self report if they choose to continue SOS meditation and several measures (questionnaires, cognitive tests, and physiological measurements) will be obtained to assess the impact of continued meditation practice on mental health and well being. |
Focused-attention meditation technique will be used to train participants, specifically the SOS meditation technique. The SOS meditation technique is an easy-to-learn approach where participants are instructed to dissociate their attention from physical awareness, thoughts, and emotions by mentally slowly repeating a calming word or phrase (chosen by the participant themselves). SOS Meditation Instructions:
|
|
Experimental: Waitlist control
Baseline to week 8: Subjects will be place in a control group which receives no intervention. However, several measures (questionnaires, cognitive tests, and physiological measurements) will be obtained to assess baseline mental health and well being scores. Week 8 to week 16: Subjects will be trained to meditate for 10 minutes daily, and several measures (questionnaires, cognitive tests, and physiological measurements) will be obtained to assess the efficacy of daily meditation practice on mental health and well being. Focused-attention meditation technique will be used to train participants. Specifically the SOS meditation technique will be employed. |
Focused-attention meditation technique will be used to train participants, specifically the SOS meditation technique. The SOS meditation technique is an easy-to-learn approach where participants are instructed to dissociate their attention from physical awareness, thoughts, and emotions by mentally slowly repeating a calming word or phrase (chosen by the participant themselves). SOS Meditation Instructions:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Generalize Anxiety Disorder Questionnaire Score
Periodo de tiempo: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Anxiety as measured using Generalize Anxiety Disorder Questionnaire |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in Pittsburgh Sleep Quality Index Questionnaire Score
Periodo de tiempo: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Sleep Quality measured using Pittsburgh sleep quality index (PSQI) |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in Mind Wandering Questionnaire Score
Periodo de tiempo: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Mind wandering measured using the Mind Wandering Questionnaire |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Resting Heart Rate
Periodo de tiempo: Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
|
Daily obtained from Activity Tracker wrist band |
Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
|
|
Heart Rate Variability
Periodo de tiempo: Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
|
Daily obtained from Activity Tracker wrist band |
Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
|
|
Change in Stroop Test Score
Periodo de tiempo: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Using the Stroop test, which measures the average reaction time between incongruent and congruent trials |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in N-back Test Score
Periodo de tiempo: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Using the N-back test is a memory task where participants must remember letters from N trials ago. |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Stress Scale Measure Questionnaire Score
Periodo de tiempo: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Stress measured using Perceived Stress Scale measure |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in Depression Questionnaire Score
Periodo de tiempo: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Depression measured using Patient Health Questionnaire |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in Quality of Life Scale Measures Questionnaire Score
Periodo de tiempo: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Quality of life measured using Quality of Life Scale measures |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change Social Connectedness Scale-Revised Questionnaire Score
Periodo de tiempo: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Social Connectedness measured using Social Connectedness Scale-Revised |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in Rumination Reflection Questionnaire Score
Periodo de tiempo: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Rumination and reflection scales measured using Rumination Reflection Questionnaire |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in Brief Strengths Scale Questionnaire Score
Periodo de tiempo: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Strengths scale measured using Brief Strengths Scale measures individuals' Temperance Strength, Intellectual Strength, and Interpersonal Strength. |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in Sleep Quality Measure
Periodo de tiempo: Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
|
Daily obtained from Activity Tracker wrist band |
Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Manish Saggar, PhD, Stanford University
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 68784
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .